These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation. Odorico JS; Pirsch JD; Knechtle SJ; D'Alessandro AM; Sollinger HW Transplantation; 1998 Dec; 66(12):1751-9. PubMed ID: 9884272 [TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine. Stegall MD; Simon M; Wachs ME; Chan L; Nolan C; Kam I Transplantation; 1997 Dec; 64(12):1695-700. PubMed ID: 9422404 [TBL] [Abstract][Full Text] [Related]
6. A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. Gruessner RW; Burke GW; Stratta R; Sollinger H; Benedetti E; Marsh C; Stock P; Boudreaux JP; Martin M; Drangstveit MB; Sutherland DE; Gruessner A Transplantation; 1996 Jan; 61(2):261-73. PubMed ID: 8600635 [TBL] [Abstract][Full Text] [Related]
8. The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence. Pham PT; Pham PC Nephrol Dial Transplant; 2012 Jul; 27(7):2965-71. PubMed ID: 22207327 [TBL] [Abstract][Full Text] [Related]
9. Outcome in cadaveric renal transplant recipients treated with cyclosporine A and mycophenolate mofetil versus cyclosporine A and azathioprine. Lee CM; Markezich AJ; Scandling JD; Dafoe DC; Alfrey EJ J Surg Res; 1998 May; 76(2):131-6. PubMed ID: 9698512 [TBL] [Abstract][Full Text] [Related]
10. The use of intravenous tacrolimus and mycophenolate mofetil as induction and maintenance immunosuppression in simultaneous pancreas--kidney recipients with previous transplants. Ciancio G; Miller J; Burke GW Clin Transplant; 2001 Apr; 15(2):142-5. PubMed ID: 11264642 [TBL] [Abstract][Full Text] [Related]
11. Lessons learned from more than 1,000 pancreas transplants at a single institution. Sutherland DE; Gruessner RW; Dunn DL; Matas AJ; Humar A; Kandaswamy R; Mauer SM; Kennedy WR; Goetz FC; Robertson RP; Gruessner AC; Najarian JS Ann Surg; 2001 Apr; 233(4):463-501. PubMed ID: 11303130 [TBL] [Abstract][Full Text] [Related]
12. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation. Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415 [TBL] [Abstract][Full Text] [Related]
14. Renal allograft and patient outcome after transplantation: pancreas-kidney versus kidney-alone transplants in type 1 diabetic patients versus kidney-alone transplants in nondiabetic patients. Douzdjian V; Rice JC; Gugliuzza KK; Fish JC; Carson RW Am J Kidney Dis; 1996 Jan; 27(1):106-16. PubMed ID: 8546124 [TBL] [Abstract][Full Text] [Related]
15. Long-term renal transplant function in recipient of simultaneous kidney and pancreas transplant maintained with two prednisone-free maintenance immunosuppressive combinations: tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus. Gallon LG; Winoto J; Chhabra D; Parker MA; Leventhal JR; Kaufman DB Transplantation; 2007 May; 83(10):1324-9. PubMed ID: 17519781 [TBL] [Abstract][Full Text] [Related]
16. Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation. Merion RM; Henry ML; Melzer JS; Sollinger HW; Sutherland DE; Taylor RJ Transplantation; 2000 Jul; 70(1):105-11. PubMed ID: 10919583 [TBL] [Abstract][Full Text] [Related]
17. Optimization of the immunosuppressive protocol after lung transplantation. Reichenspurner H; Kur F; Treede H; Meiser BM; Deutsch O; Welz A; Vogelmeier C; Schwaiblmair M; Müller C; Fürst H; Briegel J; Reichart B Transplantation; 1999 Jul; 68(1):67-71. PubMed ID: 10428269 [TBL] [Abstract][Full Text] [Related]
18. A single center's clinical experience with quadruple immunosuppression including ATG or IL2 antibodies and mycophenolate mofetil in simultaneous pancreas-kidney transplants. Hesse UJ; Troisi R; Jacobs B; Van Vlem B; de Hemptinne B; Van Holder R; Vermassen F; De Roose J; Lameire N Clin Transplant; 2000 Aug; 14(4 Pt 1):340-4. PubMed ID: 10945205 [TBL] [Abstract][Full Text] [Related]